You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Hypertension

Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]

  • In development
  • Reference number: GID-TA11572
  • Expected publication date:  17 December 2025
  • Project information
  • Project documents

29488-Treprostinil-for-Pulmonary-Hypertension-with-ILD-including-CPFE-V1.0-JAN2024-NON-CONF-.pdf (nihr.ac.uk)

Back to top